ClinicalTrials.gov
ClinicalTrials.gov Menu

Text Message Reminder-Recalls For Early Childhood Vaccination

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT01199666
Recruitment Status : Completed
First Posted : September 13, 2010
Last Update Posted : July 25, 2014
Sponsor:
Information provided by (Responsible Party):
Melissa Stockwell, MD, MPH, Columbia University

Study Description
Go to 
Study Description Study Design Arms and Interventions Outcome Measures Eligibility Criteria Contacts and Locations More Information
Brief Summary:
Although the investigators have reached the Healthy People 2010 goal of 80% coverage among U.S. children 19-35 months of age for the primary immunization series, 20% of children still remain underimmunized. In addition, pockets of low immunization coverage and outbreaks of vaccine preventable disease persist. Immunization reminder-recalls have been shown to be successful, but have been limited by the ability to identify and reach large target populations in a real-time, automated fashion. Reminder-recalls via text message may offer an innovative opportunity to improve vaccination coverage. Currently, 91% of Americans own a cell phone. Prior research by our team suggests that text messages reminder recalls may be an effective tool to remind parents about their children's vaccines. In this study, the investigators will demonstrate the effectiveness of tailored text message appointment and immunization reminders linked to a well-established and functional immunization registry to increase coverage rates and timeliness of the sentinel vaccines of MMR and HepA. The investigators will target parents of young children from an underserved population that is primarily Latino, with low socioeconomic status.

Condition or disease Intervention/treatment Phase
Vaccination Other: Text message Not Applicable

Study Design
Go to 
Study Description Study Design Arms and Interventions Outcome Measures Eligibility Criteria Contacts and Locations More Information

Study Type : Interventional  (Clinical Trial)
Actual Enrollment : 2586 participants
Allocation: Randomized
Intervention Model: Parallel Assignment
Masking: Single (Investigator)
Primary Purpose: Health Services Research
Official Title: Text 4 Health-Kids: Text Message Reminder-Recalls For Early Childhood Vaccination
Study Start Date : June 2011
Actual Primary Completion Date : July 2013
Actual Study Completion Date : July 2013
Arms and Interventions
Go to 
Study Description Study Design Arms and Interventions Outcome Measures Eligibility Criteria Contacts and Locations More Information

Arm Intervention/treatment
Experimental: Text message reminders Other: Text message
text message appointment and immunization reminders
Active Comparator: standard of care for MMR, letter reminder for Hep A
MMR: automated phone call appointment reminder Hep A: recall letter, automated phone call appointment reminder
 Other: Text message
text message appointment and immunization reminders


Outcome Measures
Go to 
Study Description Study Design Arms and Interventions Outcome Measures Eligibility Criteria Contacts and Locations More Information

Primary Outcome Measures :
  1. Receipt of MMR1 [ Time Frame: by 13 and 16 months of age ]

Secondary Outcome Measures :
  1. Timeliness of HepA vaccination post-recall [ Time Frame: 4,12, 24 weeks ]
  2. Attendance at appointments [ Time Frame: after appointment ]

Eligibility Criteria
Go to 
Study Description Study Design Arms and Interventions Outcome Measures Eligibility Criteria Contacts and Locations More Information

Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Ages Eligible for Study:   9 Months to 50 Years   (Child, Adult)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No
Criteria

Inclusion Criteria:

  • Parents of child >9 months to 25 months
  • Child with at least one visit to one of the participating clinical sites in the previous 12 months
  • Parental cell phone number recorded in the registration system
Contacts and Locations
Go to 
Study Description Study Design Arms and Interventions Outcome Measures Eligibility Criteria Contacts and Locations More Information

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT01199666


Locations
United States, New York
Columbia University Medical Center
New York, New York, United States, 10032
Sponsors and Collaborators
Columbia University
Investigators
Principal Investigator: Melissa S Stockwell, MD MPH Columbia University
Study Director: Annika Hofstetter, MD PhD MPH Columbia University
More Information
Go to 
Study Description Study Design Arms and Interventions Outcome Measures Eligibility Criteria Contacts and Locations More Information

Responsible Party: Melissa Stockwell, MD, MPH, Asst Prof of Pediatrics and Population and Family Health, Columbia University
ClinicalTrials.gov Identifier: NCT01199666     History of Changes
Other Study ID Numbers: AAAF4263
First Posted: September 13, 2010    Key Record Dates
Last Update Posted: July 25, 2014
Last Verified: July 2014

Keywords provided by Melissa Stockwell, MD, MPH, Columbia University:
Underimmunization, text message, vaccination
Underimmunization

Additional relevant MeSH terms:
Vaccines
Immunologic Factors
Physiological Effects of Drugs